Re-assessment of the Actual Benefit of all medicines indicated for menopausal hormone replacement therapy at the request of the Committee, pursuant to Article R-163-21 of the French Social Security Code
-
Clinical Benefit
Moderate
The actual benefit of the proprietary medicinal product PHYSIOGYNE 1 mg, scored tablet remains moderate in the indication in the Marketing Authorisation, in patients for whom climacteric disorders are described as bothersome enough to impair their quality of life, when these proprietary medicinal products are used as per the Committee's recommendations.
Listen
